placebo control group: Clinical Trials

5 trials of placebo control group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Unknown 1
Phase 23Completed 2, Unknown 1

Follow placebo control group: new trials by email Literature Review of placebo control group trials Research Report on placebo control group

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Research on PSMA-Targeted Intraoperative Fluorescent Imaging Agents
0.01mg/kg DGPR1008 Injection Dose Group 1 (n=6), 0.02mg/kg DGPR1008 Injection Dose Group 2 (n=6), 0.04mg/kg DGPR1008 Injection Dose Group 3 (n=6) - Prostate Cancer Patients Undergoing Radical Prostatectomy, Prostate CA
Phase 1CompletedHaitao Niu, MD322024-06-242025-08-03
The Use of Isatidis Root and Forsythia Oral Liquid for the Treatment of Mild Cases of COVID-19: A Trial Clinical Study
Langenlianqiao, LianhuaQingWen, placebo control group - Treatment of Mild Cases of COVID-19
Phase 1CompletedCentral South University2532022-11-012024-04-09
Rapid Delivery of Autologous Bone Marrow Derived Stem Cells in Acute Myocardial Infarction Patients.
Autologous Bone marrow mononuclear cells, Placebo control - Acute Myocardial Infarction
Phase 1 / Phase 2UnknownTotipotentRX Cell Therapy Pvt. Ltd.302013-12-012013-09-04
Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke
Autologous BMSCs transplantation, Autologous EPCs transplantation, IV infusion of placebo - Stroke, Infarction, Middle Cerebral Artery
Phase 1 / Phase 2CompletedSouthern Medical University, China202011-11-012021-04-02
Green Tea and Tai Chi for Bone Health
Placebo, Green Tea Polyphenols (GTP), Placebo+Tai Chi (TC) - Osteoporosis
Phase 1 / Phase 2CompletedTexas Tech University Health Sciences Center1712008-02-012014-08-18

Conditions studied

Central Nervous System Diseases (1)  ·  Cerebral Infarction (1)  ·  Infarction, Middle Cerebral Artery (1)  ·  Osteoporosis (1)  ·  Stroke (1)

Sponsors

Central South University (1)  ·  Haitao Niu, MD (1)  ·  Southern Medical University, China (1)  ·  Texas Tech University Health Sciences Center (1)  ·  TotipotentRX Cell Therapy Pvt. Ltd. (1)

Countries

China (3)  ·  India (1)  ·  United States (1)

Top investigators

Ashok Seth, FRCP, FACC (1)  ·  Kenneth Harris, MS (1)  ·  Sreenivas A Kumar, MD, DM, FACC (1)  ·  Upendra Kaul, MD,DM, FACC (1)  ·  Venkatesh Ponemone, PhD (1)  ·  Zhenzhou Chen, MD., phD. (1)

Results publications

PMID 18598362, PMID 20576835, PMID 21127322, PMID 21143878, PMID 21766228, PMID 23118932, PMID 30156755

NIH funding

R21AT003735 (1)